Lack of synergy between AR-targeted therapies and PARP inhibitors in homologous recombination–proficient prostate cancer - Nicole A. Traphagen; Esmé Wheeler; Rong Li; Tara Akhshi; Ramya Ravindranathan; Christian Alfieri; Feng Lu; Buraq Ahmed; Alok K. Tewari; Steven P. Balk; Peter S. Nelson; Eva Corey; et al. (Proceedings of the National Academy of Sciences, 2026)